Ultragenyx Pharmaceutical reported $3.61B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.28B 1.63B
Agios Pharmaceuticals AGIO:US $ 1.22B 0.38B
Alnylam Pharmaceuticals ALNY:US $ 17.65B 2.06B
Aptinyx Inc APTX:US $ 0.04B 0.12B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Biomarin Pharmaceutical BMRN:US $ 15.33B 1.08B
Bluebird Bio BLUE:US $ 0.3B 0.05B
Epizyme EPZM:US $ 0.25B 0.06B
Esperion Therapeutics ESPR:US $ 0.4B 0.11B
Insmed INSM:US $ 2.36B 0.43B
IONIS PHARMACEUT IONS:US $ 5.25B 0B
Karyopharm Therapeutics KPTI:US $ 0.36B 0.22B
Kyowa Hakko Kirin 4151:JP 1647B 109.08B
Macrogenics MGNX:US $ 0.18B 0.36B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Moderna Inc MRNA:US $ 56.82B 12.6B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Ptc Therapeutics PTCT:US $ 2.86B 0.2B
Puma Biotechnology PBYI:US $ 0.13B 0.01B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Ultragenyx Pharmaceutical RARE:US $ 4.17B 0.87B
Vertex Pharmaceuticals VRTX:US $ 72.14B 5.45B
Vital Therapies VTL:US $ 0.08B 0.25B
Xoma XOMA:US $ 0.26B 0.06B